← Open Payments lookup

IMELDA RUSSELL: Open Payments

NPI 1528163540 · RIVERDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$432 in 22 payments from 8 companies in 2025. Trend: 2023 $981 · 2024 $145 · 2025 $432

Food & beverage: $432
CompanyPaymentsAmount
Gilead Sciences, Inc.10$155
ABBVIE INC.5$113
Merck Sharp & Dohme LLC2$38
Aimmune Therapeutics, Inc.1$32
Astellas Pharma US Inc1$29
Shionogi Inc1$23
Melinta Therapeutics, LLC1$22
Theratechnologies Inc.1$21

Products named: DALVANCE, EMBLAVEO, ZERBAXA, ZENPEP, Cresemba, Fetroja, Rezzayo, EGRIFTA.

Industry payments across MD — which companies pay providers there.